Introduction: Atrial fibrillation (AF) is the most common arrhythmia in adults, accounting about approximately one third of all hospitalizations for arrhythmia. A key issue in any case of PM is - what is the risk of recurrent episode and what to do that this episode will not happen again. If the rhythm restoration capabilities with a variety of modern drugs, the retention of heart rate is much more complex and often leads to major clinical problems. There is no consensus about the possible risk markers in patients with moderate heart failure, metabolic syndrome (MS) and diabetes mellitus (DM) what in to the developed countries threatens to develop into a pandemic. Clarification of specific markers and their association with AF recurrence rate would help to choose the appropriate treatment method and means.
Objectives, Materials and Methods: The study analyzed data of patients undergoing electrical cardioversion due to PM paroxysm. Observation period was 12 months. Patients were divided in two groups - patients with new-onset episode of PM and PM patients with recurrent episode. As control group were taken the data of patients who underwent electrical cardioversion, but were none of the above clinical conditions. Were analyzed data from the Echocardiographic examination, glycohemoglobin, body mass index, C reactive protein, natriuretic peptide, cholesterol and its fractions.
Results: In total were analyzed, 866 patients' data, who, during the period from year 2010 to-year 2012 went under electrocardioversion. First-time PM paroxysm was found in 648 patients, 367 patients were with MS or DM. PM recurrences were detected in 294 patients. Evaluating the paroxysm recurrence rate depending on co-morbidities, there was a certain pattern which makes it easier to predict the likelihood of recurrence.
Conclusions: There are clearly some risk factors that can provoke PM, but is not specified, are there existence of different predisposing factors for first-time PM and PM recurrent episodes in specific high-risk group patients with moderate heart failure, metabolic syndrome and diabetes.